CClinicalTrials.gg
CompletedNCT03740412INTERESTUpdated Jul 5, 2019

Study to Reduce Sitting in Older Adults Undergoing Hip or Knee Replacements

An interventional study of Sedentary behaviour reduction using motivational interviewing, education, individualised feedback, goal-setting, self-monitoring, environmental modification, and supportive phone calls in Orthopedic Disorder, Arthropathy of Knee and Arthropathy of Hip, sponsored by University of Birmingham. Completed at 1 site in United Kingdom. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2019-07-05.

Sponsored by University of Birmingham · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

The aim of this study is to investigate the feasibility of an intervention to reduce sedentary behaviour in older adults waiting for hip and knee replacements. The study will be a randomised controlled trial design, including 2:1 randomisation into an intervention and usual care group respectively. A target of n=45 patients ≥60 years will be recruited from Russells Hall Hospital, Dudley, UK, approximately 8-10 weeks before surgery, assisted by research nurses. The variable-length intervention, informed by Self-Determination Theory (SDT), will be composed of multiple behaviour change techniques, namely motivational interviewing, individualised feedback on sedentariness, goal-setting, environmental modification, self-monitoring, and social support. Assessments will occur at baseline, 1 week pre-surgery, and 6 weeks post-surgery. The primary outcome will be the feasibility of the trial, assessed quantitatively using study statistics, and with mixed-methods assessment of acceptability, practicality, adaption, satisfaction, and safety via questionnaires given to participants. Exploratory outcomes will include physical function, cardiometabolic biomarkers, measurement of SDT constructs, and both objective and subjective measurement daily activity and sedentariness. The study will last up to 18 weeks per participant.

Read the detailed description

The aim of this study is to investigate the feasibility of an intervention to reduce sedentary behaviour in n=45 older adults undergoing orthopaedic surgery, at Russells Hall Hospital, Dudley, Birmingham, UK. Recruitment will be via screening of surgery lists followed by direct contact with potentially eligible participants. The intervention is designed utilising Self Determination Theory. It is designed to have multiple components: incorporating individualised feedback on sitting time, education about sedentary behaviour, individualised goal-setting and environmental modification according to each participant's own behavioural patterns and capabilities, motivational interviewing, and biweekly phone calls.

Due to variation in surgery times, the intervention will be variable but can last up to 18 weeks. Each participant will undertake 3-5 visits depending on whether they are in the control group (n=3 visits) or intervention group (n=5 visits). The intervention group will undergo baseline assessments, two intervention meetings, pre-surgical assessments, and a 6-week post-surgical follow up. These visits will occur in different weeks for each participant due to the variability of surgery, however visit 2 will occur 1 week after visit 1. Visit 3 will occur shortly thereafter but may also be combined with visit 2. Visit 4 will occur the week prior to surgery, which is intended to be 6-10 weeks after baseline. Visit 5 occurs 6 weeks post-surgery, which should be 12-18 weeks post-baseline. The primary outcome measure will be feasibility, assessed quantitatively with study statistics. Secondary outcome will be mixed-methods assessment of feasibility via bespoke participant questionnaires. Exploratory outcomes will cover a number of mental and physical health variables, including blood measures to assess cardiometabolic biomarkers, as well as physical function using the short physical performance battery (SPPB). Surgical recovery will be assessed using the Oxford Hip/Knee score and the SPPB. The results of this feasibility study will serve to aid the design of a definitive trial of an intervention to reduce sedentary behaviour in this population.

02

Conditions studied

  • Orthopedic Disorder
  • Arthropathy of Knee
  • Arthropathy of Hip
  • Sedentary Lifestyle
  • Physical Activity
  • Osteoarthritis

Keywords

  • sedentary
  • arthroplasty
  • osteoarthritis
  • older adults
  • elderly
  • old
  • elders
  • sitting
  • intervention
03

In context

Osteoarthritis

4,397 studies on the registry are indexed under Osteoarthritis; 581 are open to participants now.

This study's enrollment of 35 is below the median of 70 across 3,440 interventional studies indexed under Osteoarthritis.

Browse Osteoarthritis studies →

Lead sponsor

University of Birmingham is the lead sponsor of 179 studies on the registry; 30 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Men and women aged ≥60 years.
  2. Listed for elective hip or knee surgery.
  3. Capable of providing informed consent.
  4. Regular access to a phone at pre-specified times.
  5. Able to speak English.

Exclusion criteria

Exclusion Criteria:

  1. Neuromuscular impairments that preclude participating in physical activity, visual, hearing, or moderate/ severe cognitive impairments as indicated by the research nurse prior to recruitment.
  2. Significant co-morbid disease that would pose a safety threat, affect blood measures significantly, or impair ability to participate such as coronary artery disease, severe hypertension, peripheral vascular disease, stroke, congestive heart failure, chronic obstructive pulmonary disease, insulin-dependent diabetes, psychiatric disease, renal disease, liver disease, or an active cancer other than skin cancer.
  3. Working more than 2 days per week.
  4. Unwillingness or inability to comply with the intervention.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
35 participants (actual)

Study arms

  • Experimental
    Sedentary behaviour reduction (behaviour change techniques)

    Intervention group attending visits 1, 2, 3, 4, 5

    Behavioral: Sedentary behaviour reduction using motivational interviewing, education, individualised feedback, goal-setting, self-monitoring, environmental modification, and supportive phone calls

  • No intervention
    Usual care

    Will receive usual orthopaedic care, attending visits 1, 4, 5

Interventions

  • BehavioralSedentary behaviour reduction using motivational interviewing, education, individualised feedback, goal-setting, self-monitoring, environmental modification, and supportive phone calls

    The intervention has multiple components in order to reduce sedentary behaviour, namely: incorporating individualised feedback on sitting time, education about sedentary behaviour, individualised goal-setting and environmental modification according to each participant's own behavioural patterns and capabilities, motivational interviewing, and biweekly phone calls.

06

What researchers measure

Primary outcomes

  1. Study uptake rates (as % of those approached who are randomised, recruitment rates (N/mth)

    Study uptake rates (as % of those approached who are randomised, recruitment rates (N/mth)

    Time frame: Assessed post-study-endpoint (up to month 18)

  2. Intervention adherence to goals

    Self-recording by participants of goal achievement on a scale of 1-5, recorded each week for the first 6 weeks of the intervention in their goal-setting booklet.

    Time frame: Assessed post-study-endpoint (up to month 18)

  3. Percentage of participants whose surgery is scheduled up to 2 weeks prior to the end of the intervention

    Percentage of participants whose surgery is scheduled up to 2 weeks prior to the end of the intervention

    Time frame: Assessed post-study-endpoint (up to month 18)

  4. Percentage of participants whose surgery is scheduled up to three weeks after the end of the intervention

    Percentage of participants whose surgery is scheduled up to three weeks after the end of the intervention

    Time frame: Assessed post-study-endpoint (up to month 18)

  5. Percentage of participants whose surgery is cancelled or delayed for too long

    Percentage of participants whose surgery is delayed beyond 3 weeks post-intervention

    Time frame: Assessed post-study-endpoint (up to month 18)

  6. Retention rates (% of participants randomised who provide data at follow-up)

    Assessed by the number of participants who attend the follow-up visit (visit 5, 6 weeks post-surgery)

    Time frame: Assessed post-study-endpoint (up to month 18)

  7. Acceptability of intervention for participants

    Assessed by custom-made feasibility questionnaire which uses a number of closed and open questions. Closed questions include (Likert 1-5 scale): How easy was it to achieve your goals physically? How easy was it to achieve your goals mentally? Have you found taking part in the study burdensome?

    Time frame: Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)

  8. Practicality of intervention for participants

    Assessed by custom-made feasibility questionnaires, using both closed and open questions. Closed questions include (1-5 Likert scale): Could you have changed your goals to make them more achievable? Which part(s) of the intervention did you find most difficult?

    Time frame: Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)

  9. Participant satisfaction with the study

    Whether patients are satisfied, as assessed by feasibility questionnaires given at visit 4 (week prior to surgery) and visit 5 (week post-surgery). This included open and closed questions. Closed questions include (Likert scale 1-5): Which part(s) of the intervention did you find most enjoyable? How would you rate your overall satisfaction with the study? How likely would you be to suggest taking part in such a study to friends or family? How likely are you to continue working towards your goals in the future?

    Time frame: Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)

  10. Patient perception of the safety of the study as assessed by questionnaire

    Any change in patient safety as assessed by custom-made feasibility questionnaires. This includes closed and open questions. Closed questions include (Likert 1-3 scale): Do you feel that taking part in the study has exposed you to more pain? Do you feel that taking part in the study has exposed you to risk of physical harm?

    Time frame: Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)

Secondary outcomes

  1. Short Physical Performance Battery (SPPB)

    Short Physical Performance Battery (SPPB)

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)

  2. Sitting time

    Assessed via activpal, mean minutes per day

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)

  3. Standing time

    Assessed via activpal, mean minutes per day

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)

  4. Stepping time

    Assessed via activpal, mean minutes per day

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)

  5. Sit-to-stand transitions

    Assessed via activpal, n/day

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)

  6. Quantity of sedentary bouts >30 minutes

    Assessed via activpal, n/day

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)

  7. Measure of Older Adults' Sedentary Time (MOST)

    Measure of Older Adults' Sedentary Time (MOST)

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)

  8. EuroQol five dimensions questionnaire (EQ-5D)

    EuroQol five dimensions questionnaire (EQ-5D) Assessed for each subscale (1-5 score on each); Mobility, Self-Care, Usual Activities, Pain, and Anxiety

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)

  9. EQ-VAS

    Scale of overall perceived health on that day: scale 1-100 (100 is best, 0 is worst)

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)

  10. Oxford Hip/Knee Score

    Oxford Hip/Knee Score. Reported as a scale from 0-48, where 0 is the most severe hip/knee osteoarthritis, and 48 is no indication of hip/knee osteoarthritis.

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)

  11. Basic Psychological Needs Scale

    Three subscales: autonomy, relatedness, and competence. R equals reverse scoring. Max score for each is 49. Total score is not computed. Autonomy: 1, 4(R), 8, 11(R), 14, 17, 20(R) Competence: 3(R), 5, 10, 13, 15(R), 19(R) Relatedness: 2, 6, 7(R), 9, 12, 16(R), 18(R), 21

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)

  12. International Physical Activity Questionnaire (IPAQ) Short Form

    The International Physical Activity Questionnaire (IPAQ) Short Form asks the amount of hours spent doing vigorous, moderate, and walking activities per day, and for how many days. It also asks for the average perceived sitting time per day.This gives a score for self-reported Vigorous Physical Activity, Moderate Physical Activity, Walking, and Sitting time.

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)

  13. Katz Activites of Daily Living

    Each item assess independence, in several domains, namely has a maximal overall score of 6 indicating maximal independence. The items are Bathing, Dressing, Toileting, Continence, Transferring (from bed to chair) and Feeding.

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)

  14. Body weight

    KGs

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10), post-surgery (visit 5, up to week 18)

  15. Height

    CMs

    Time frame: Baseline (visit 1, week 1)

  16. Body mass index

    kg/m2

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)

  17. Waist to hip ratio

    Waist to Hip Ratio (WHR) = Gw / Gh

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)

  18. Short Form Mini Nutritional Assessment (SF-MNA)

    Short Form Mini Nutritional Assessment (SF-MNA). Gives a scale from 0-14, where 0 is most severely malnourished.

    Time frame: Baseline (visit 1, week 1)

  19. Albumin concentration

    Albumin

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)

  20. High Density Lipoprotein concentration

    High Density Lipoprotein

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)

  21. Low density lipoprotein concentration

    Low density lipoprotein

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)

  22. Triglyceride concentration

    Triglycerides

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)

  23. Vitamin D level

    Vitamin D

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)

  24. C-Reactive Protein concentration

    C-Reactive Protein

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)

  25. Interleukin 6 concentration

    Interleukin 6

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)

  26. Tumor Necrosis Factor Alpha concentration

    Tumor Necrosis Factor Alpha

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)

  27. Cortisol concentration

    Cortisol

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)

  28. Dehydroepiandrosterone sulfate (DHEAS) concentration

    Dehydroepiandrosterone sulfate

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)

  29. Transferrin concentration

    Transferrin

    Time frame: Baseline (visit 1, week 1), Pre-surgery (visit 4, up to week 10)

07

Study locations

1 site
  • Russells Hall Hospital
    Dudley, West Midlands DY1 2HQ, United Kingdom
08

References and documents

Publications

  • Aunger JA, Greaves CJ, Davis ET, Asamane EA, Whittaker AC, Greig CA. A novel behavioural INTErvention to REduce Sitting Time in older adults undergoing orthopaedic surgery (INTEREST): results of a randomised-controlled feasibility study. Aging Clin Exp Res. 2020 Dec;32(12):2565-2585. doi: 10.1007/s40520-020-01475-6. Epub 2020 Jan 23. PubMed 31975288 ↗
  • Aunger JA, Greaves CJ, Davis ET, Greig CA. A novel behavioural INTErvention to REduce Sitting Time in older adults undergoing orthopaedic surgery (INTEREST): protocol for a randomised controlled feasibility study. Pilot Feasibility Stud. 2019 Apr 6;5:54. doi: 10.1186/s40814-019-0437-2. eCollection 2019. PubMed 30997142 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 5, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03740412
Lead sponsor
University of Birmingham
Collaborators
European Commission, Dudley NHS Foundation Trust
Responsible party
Sponsor
First posted
Nov 14, 2018
Start date
Jan 29, 2018
Primary completion
Apr 15, 2019
Completion
Apr 15, 2019
Last update
Jul 5, 2019

Study contacts

Justin Aunger, BA
principal investigator · Principal Investigator

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion